Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChitoLytic
St. John's, Newfoundland and Labrador, Canadachitolytic.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
ChitoLytic is a North American biotech company specializing in the manufacture and supply of high-quality chitosan for R&D and commercial use. Their products are used in biomedical, pharmaceutical, medical device, nutraceutical, cosmetic, food/agriculture industries. They do not develop proprietary drugs or therapies but enable research and product development through their materials.
- Therapeutic areas
- OtherDermatology
- Modalities
- BiologicRecombinant protein (chitosan and derivatives)Nanoparticle (for drug delivery applications)
- Industry
- Non-Drug Biotech
02
Partnerships
Academic partnership with Flinders University/Centre for Marine Bioproducts Development to scale up all-natural sunscreen technology using chitosan
Beyond the preview
Go deeper on ChitoLytic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChitoLytic.